Add 2 More Reports For 20% off

Report Overview

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis. It is considered the leading cause of death from a single infectious agent. According to the World Health Organisation (WHO), around 10.8 people worldwide were affected by tuberculosis in 2023 and about 1.25 million people died from the bacterial infection.

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Tuberculosis Epidemiology Forecast Report Coverage

Expert Market Research's “Tuberculosis Epidemiology Forecast Report 2024-2032” offers comprehensive information on the prevalence and demographics of tuberculosis. It projects the future incidence and prevalence rates of tuberculosis across various populations. The study covers age, gender, and type as major determinants of the tuberculosis-affected population. The report highlights patterns in the prevalence of tuberculosis over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of tuberculosis in the 8 major markets.

Regions Covered

  • The United States
  • Germany
    • France
    • Italy
    • Spain
    • The United Kingdom
  • Japan
  • India

Tuberculosis Disease Overview

Tuberculosis, also known as the white death, refers to a multisystem disease with various clinical manifestations. It usually affects the lungs and can spread to other parts of the body like the brain. Tuberculosis can be treated with antibiotics but can be fatal if left untreated. Common symptoms include fever, persistent cough, chest pain, coughing up blood and mucus, and fatigue, among others. In certain regions, infants and children are vaccinated with Bacille Calmette-Guérin (BCG) vaccine to protect them against tuberculosis infection.

Tuberculosis: Treatment Overview

The treatment for tuberculosis usually involves a combination of antibiotics which are taken over several months. First-line drugs include isoniazid (inhibits mycolic acid synthesis which is needed for bacterial cell walls), rifampin (suppresses bacterial RNA synthesis), pyrazinamide (targets semi-dormant bacteria), and ethambutol (inhibits bacterial cell wall formation). For drug-resistant tuberculosis, second-like drugs like linezolid, fluoroquinolones, and Bedaquiline are commonly prescribed for a period of 18 to 24 months.

Epidemiology

The tuberculosis epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for tuberculosis by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for tuberculosis and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

  • In 2023, around 10.8 million people were affected by tuberculosis globally and 1.25 million died from the bacterial disease, according to the World Health Organisation (WHO).
  • As per the Central TB Division, Ministry of Health and Family Welfare (India), approximately 10 million people are affected by tuberculosis annually, out of which nearly 3.2 million of the patient population is women.
  • The Global TB Report 2022 estimated the incident cases of tuberculosis in 2021 to be 10.6 million.
  • According to the Centers for Disease Control and Prevention (CDC), the 50 U.S. states and DC reported 9615 cases of tuberculosis in 2023, the highest number of cases reported since 2013.

Country-wise Tuberculosis Epidemiology

The tuberculosis epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of tuberculosis varies between countries due to several factors including access to treatment facilities, socioeconomic conditions, public health policies, HIV co-infection rates, and the prevalence of multidrug-resistant tuberculosis, among others. India is reported to have the world’s highest annual incidence of tuberculosis along with the highest tuberculosis-related mortality. According to a modeling study published in the Indian Journal of Community Medicine (2023), the incidence of tuberculosis was estimated to be 2.77 million in 2022 in the country.

Country Specific Stats:

Country

Prevalence (Unit)

United States

XX

United Kingdom

XX

Germany

XX

Italy

XX

France

XX

Spain

XX

Japan

XX

India

25% of the global tuberculosis burden

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of tuberculosis based on several factors.
  • Tuberculosis Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population and the unmet needs of tuberculosis are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of tuberculosis epidemiology in the 8 major markets?
  • What will be the total number of patients with tuberculosis across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of tuberculosis in the 8 major markets in the historical period?
  • Which country will have the highest number of tuberculosis patients during the forecast period of 2024-2032?
  • Which key factors would influence the shift in the patient population of tuberculosis during the forecast period of 2024-2032?
  • What are the currently available treatments for tuberculosis?
  • What are the disease risks, signs, symptoms, and unmet needs of tuberculosis?

Related Reports

Global Tuberculosis Treatment Market

Anti Tuberculosis Therapeutics Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2023

Historical Period

2017-2023

Forecast Period

2024-2032

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
    • Italy
    • France
    • Spain
    • United Kingdom
  • Japan
  • India

Purchase Full Report

Datasheet

 

USD 2,199

USD 1,999

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 3,299

USD 2,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 4,399

USD 3,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124